|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/04 | |
| C07D 403/04 | |||
| C07D 471/04 | |||
| A61K 31/506 | |||
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Patento numeris | 3039015 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13892399.0 |
| Europos patento paraiškos padavimo data | 2013-11-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-07-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/071216 |
| Data | 2013-11-21 |
| (87) | Numeris | WO 2015/030847 |
| Data | 2015-03-05 |
| (30) | Numeris | Data | Šalis |
| 201361872091 P | 2013-08-30 | US |
| (72) |
DU, Wu, US
BAIAZITOV, Ramil, US
LEE, Chang-sun, US
MOON, Young-Choon, US
PAGET, Steven D., US
REN, Hongyu, US
SYDORENKO, Nadiya, US
WILDE, Richard Gerald, US
|
| (73) |
PTC Therapeutics, Inc.,
100 Corporate Court,, South Plainfield, NJ 07080,
US
|
| (54) | SUBSTITUTED PYRIMIDINE BMI-1 INHIBITORS |
| SUBSTITUTED PYRIMIDINE BMI-1 INHIBITORS |